Anil Goyal

Anil Goyal

Company: IMMvention Therapeutix

Job title: Chief Executive Officer & Board Director


Breakfast C-Level Panel Discussion: Overcoming Challenges in the Field & Current Thoughts on Progress 9:00 am

Thinking outside the box when it comes to disease indications to identify and prioritize for inflammasome therapeutic success Balancing commercial considerations of drug development with unmet need across diseases How crucial is it to demonstrate differentiation from standards of care or other inflammasome inhibitors? Should you plan for comparative data with standards of care in…Read more

day: Day Two

IMM-004 small molecule series that inhibits NLRP3, NLPR1, NLRC4 & AIM2 2:30 pm

Session details to be announcedRead more

day: Day 1 - Track A - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.